Skip to content

084990.KQ

Helixmith Co., Ltd

KOE · Healthcare · Biotechnology · KR

KRW 2,955.00
+0.34%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue2.4B2.6B5.0B4.2B2.8B
Cost of Revenue3.7B3.4B2.1B2.1B12.8B
Gross Profit(1.3B)(804.6M)2.9B2.1B(10.0B)
Operating Expenses
R&D Expense1.9B1.7B6.6B17.1B28.1B
SG&A Expense4.6B3.5B6.7B10.9B23.3B
General & Admin Expense874.6M1.2B2.2B2.8B3.4B
Selling & Marketing Expense1.8B2.3B4.4B8.1B9.4B
Other Expenses2.2B4.0B7.5B9.3B(8.8B)
Total Operating Expenses8.1B9.1B20.8B37.4B42.6B
Cost and Expenses11.8B12.5B22.9B39.4B55.4B
Operating Income (EBIT)(9.4B)(9.9B)(18.0B)(35.2B)(52.6B)
Non-Operating
Interest Income821.0M1.1B3.7B3.2B2.3B
Interest Expense36.3M5.7M162.3M582.4M2.1B
Net Interest Income784.7M1.0B3.6B2.6B219.8M
Other Non-Op Income/Expense7.8B9.4B2.5B(29.0B)9.6B
Non-Operating Income (excl Interest)(6.9B)(2.6B)28.5B(11.6B)
EBT (Pre-Tax Income)(1.6B)(460.1M)(15.5B)(64.3B)(43.0B)
Income Tax Expense(100.0M)57.5M
Bottom Line
Net Income(1.6B)(434.9M)(15.5B)(64.1B)(43.5B)
Earnings from Cont. Ops(1.6B)(460.1M)(15.5B)(64.2B)(43.1B)
Earnings from Discont. Ops
Bottom Line Net Income(1.6B)(434.9M)(15.5B)(64.1B)(43.5B)
Per Share
Basic EPS(₩35)(₩9)(₩329)(₩1,544)(₩1,154)
Diluted EPS(₩35)(₩9)(₩329)(₩1,544)(₩1,154)
Revenue Per Share₩53₩56₩106₩101₩74
Shares
Basic Shares Outstanding46.0M46.1M47.0M41.5M37.7M
Diluted Shares Outstanding46.0M46.1M47.0M41.5M37.7M
Profitability Metrics
EBITDA(6.1B)(8.1B)(11.1B)(53.0B)(30.5B)
D&A1.6B1.8B4.2B10.7B10.4B
EBIT(7.7B)(9.9B)(15.3B)(63.7B)(40.9B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026